Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Mydecine Innovations Group Inc (MYCO.CN)

Mydecine Innovations Group Inc (MYCO.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mydecine Innovations Group Inc 789 West Pender Street Suite 810

P: 720-277-9879

Description:

Mydecine Innovations Group Inc is a biopharma and life sciences company. It is committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use. Reinforcing Mydecine's commitment to mental health solutions is underpinned by the company's three main focuses: Clinical Trials focusing on Veterans, EMS, and First Responders with a PTSD indication; Research and Development building a robust portfolio of intellectual property around drug discovery and unique delivery mechanisms with relevant use patents and future patent applications and Modern technology utilizing for better clinical trial management and mental health wellbeing.

Key Statistics

Overview:

Market Capitalization, $K 74,871
Shares Outstanding, K 162,763
Annual Sales, $ 126 K
Annual Net Income, $ -3,508 K
Last Quarter Sales, $ 17 K
Last Quarter Net Income, $ -11,396 K
60-Month Beta 3.49
% of Institutional Shareholders 0.04%

Growth:

1-Year Return 471.43%
3-Year Return -92.59%
5-Year Return -64.44%
5-Year Revenue Growth 8.37%

Per-Share Information:

Most Recent Earnings -0.08 on 09/30/20
Next Earnings Date N/A
Earnings Per Share ttm -0.11
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-45 on 04/01/19

MYCO.CN Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -95.12%
Return-on-Assets % -86.59%
Net Margin % -230.62
Debt/Equity 0.02
Price/Sales 1,088.43
Price/Cash Flow N/A
Price/Book 7.52
Book Value/Share 0.06
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar